Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Propofol in DISE
NCT03892122Phase 4Unknown
- Sponsor
- Ospedale Monsignor R. Dimiccoli
- Start
- Mar 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine in obstructive sleep apnea (OSA) (2 arms), sponsored by Ospedale Monsignor R. Dimiccoli. Primary endpoints: oxygen saturation variation during DISE, heart rate variation during DISE and 2 more. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03892122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03892122.